Financials in USD. Standardized financial statements.
A compact view of how Lucy Scientific Discovery Inc. turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Revenue? | $7,048 | $0 | $0 | $0 |
| Revenue Growth? | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $4,500 | $0 | $0 | $0 |
| Gross Profit? | $2,548 | $0 | $0 | $0 |
| Gross Margin? | +36.2% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $5.77M | $3.47M | $2.51M | $2.86M |
| Operating Income? | -$5.84M | -$3.79M | -$2.49M | -$2.86M |
| EBITDA? | -$5.66M | -$3.47M | -$2.49M | -$2.86M |
| Income Before Tax | -$8.99M | -$5.86M | -$4.73M | -$3.56M |
| Income Tax Expense | $0 | $322,226 | $2.38M | -$559,729 |
| Net Income? | -$8.99M | -$6.18M | -$7.10M | -$3.00M |
| EPS? | $-0.71 | $-0.38 | $-0.44 | $-0.19 |
| Diluted EPS? | $-0.71 | $-0.38 | $-0.44 | $-0.19 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality